Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-020852
Filing Date
2019-03-21
Accepted
2019-03-21 19:16:37
Documents
1
Period of Report
2019-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3984
  Complete submission text file 0001209191-19-020852.txt   5389
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 5105213390
BIOTIME INC (Issuer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INVIVO THERAPEUTICS HOLDING CORP. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Wirth Edward (Reporting) CIK: 0001532558 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12830 | Film No.: 19698121